Granules India Ltd. Share Price NSE India S.E.
Equities
INE101D01012
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- INR | - |
|
15/05 | Transcript : Granules India Limited, Q4 2024 Earnings Call, May 15, 2024 | |
15/05 | Granules India Posts Decline in Fiscal Q4 Consolidated Net Profit, Revenue | MT |
Sales 2024 | 4.51TCr 54Cr | Sales 2025 * | 5.09TCr 61Cr | Capitalization | 12TCr 138.95Cr |
---|---|---|---|---|---|
Net income 2024 | 405.3Cr 4.86Cr | Net income 2025 * | 580.3Cr 6.95Cr | EV / Sales 2024 | 2.31 x |
Net Debt 2024 * | 812.6Cr 9.73Cr | Net Debt 2025 * | 796.4Cr 9.54Cr | EV / Sales 2025 * | 2.43 x |
P/E ratio 2024 |
25.7
x | P/E ratio 2025 * |
19.9
x | Employees | - |
Yield 2024 * |
0.29% | Yield 2025 * |
0.29% | Free-Float | 53.27% |
Latest transcript on Granules India Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 05/22/05 | |
Chief Executive Officer | 69 | 18/91/18 | |
Mukesh Surana
DFI | Director of Finance/CFO | 44 | 30/22/30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 70 | 19/13/19 | |
Director/Board Member | 62 | 13/21/13 | |
Director/Board Member | 67 | 20/02 |
1st Jan change | Capi. | |
---|---|---|
+48.10% | 77TCr | |
-6.18% | 35TCr | |
+20.48% | 33TCr | |
+9.89% | 30TCr | |
+18.87% | 25TCr | |
-1.96% | 22TCr | |
+11.11% | 22TCr | |
+5.29% | 16TCr | |
-2.45% | 16TCr |